CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,144 | -96.4% | 4,148 | -89.7% | 0.00% | -100.0% |
| Q1 2023 | $143,942 | +25.1% | 40,320 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $115,103 | +27.9% | 40,387 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $90,000 | -41.9% | 40,387 | -35.0% | 0.00% | 0.0% |
| Q2 2022 | $155,000 | +19.2% | 62,163 | +133.4% | 0.00% | 0.0% |
| Q1 2022 | $130,000 | -32.6% | 26,633 | +101.5% | 0.00% | -50.0% |
| Q3 2021 | $193,000 | -36.5% | 13,216 | -49.4% | 0.00% | -33.3% |
| Q2 2021 | $304,000 | +106.8% | 26,134 | +123.0% | 0.00% | +50.0% |
| Q4 2020 | $147,000 | -72.4% | 11,718 | -46.1% | 0.00% | -77.8% |
| Q2 2020 | $532,000 | – | 21,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LP | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |